Analytical study identifies mutations associated with poor prognosis in uveal melanoma, suggesting improved patient management.
Mutations in BAP1, CHEK2, and DICER1 are independently associated with poorer prognosis in UM, while SF3B1 defines a distinct histologic subgroup. Routine mutational profiling by targeted NGS may aid in risk stratification and follow-up of UM patients.
No takes yet. Share an insight, caveat, or question.
Pérez-Pérez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: